Euronanomed III - Euronanomed III
Gut-targeted RNA-based nanoparticles for fibrostenotic Crohn’s Disease: a novel therapeutic approach – RuNNINg
Project coordination
ICH ()
The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.
Partnership
BIOEMTECH
VAXINANO
ICH
SINTEF Industry
Help of the ANR 89,842 euros
Beginning and duration of the scientific project:
February 2020
- 36 Months
